We will be attending this year’s DIA Annual Meeting, June 24-28, at the Boston Convention & Exhibition Center.
If you are planning to be there, we would really like to meet up with you!
Over the last 5 years, NDA Group has supported the approval of over 40% of new medicinal products in the EU and among our FDA advisory committee clients 80% have achieved product approval. We work across a range of disease areas including oncology, hematology, infectious disease, metabolic and immunologic disorders and CNS and have supported the development of over 50 rare disease programs.
Do you want your product to reach the world’s two largest markets with minimum delay? Arrange to meet us at DIA USA 2018 now.
Four of our Experts will be presenting at the event:
and Lisa Peluso – Director, Coaching and Client Engagement, PharmApprove, a member of the NDA Group
Sunday, June 24 | 08:30-12:00
#24: Preparing for a US FDA Advisory Committee Meeting
Monday, June 25 | 15:00-16:15
#140: How Inspection Ready is your Organization?
Tuesday, June 26 | 16:15-17:30
#276: Patient Engagement in Pharmacovigilance
Wednesday, June 27 | 12:45-13:15
#351: Moving Forward with the EU Vigil: The Patient Contact in Pharmacovigilance
Dr Edwards will also be involved in the following DIA Community Round Table Discussions taking place at the DIA Community Zone, North East Lobby, BCEC.
Host Community: Clinical Safety & Pharmacovigilance
Tuesday, 26 June | 15:15-16:15
01 7027101 – Risk Management: New Direction
Wednesday, 27 June | 08:00-09:00
01 7027113 – Pharmacovigilance: No Longer Going it Alone
Wednesday, 27 June | 13:00-14:00
01 7027109 – Patient Engagement in Pharmacovigilance
Click here to download the Final Programme.
Meet us at the DIA Annual Meeting in Boston
To book a meeting contact Anna Perrin: email@example.com
We look forward to hearing back from you about a meeting and to seeing you at the event!